Servatus strengthens board with new appointment

Servatus Limited, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, ...

May 4, 2022 | Wednesday | News
Incyte and Maruho lay focus on inflammatory dermatologic diseases in Japan

Incyte and Maruho Co., Ltd. have announced that the companies have entered into a Strategic Alliance Agreement for the d...

May 3, 2022 | Tuesday | News
Visirna brings RNAi therapeutics for cardiovascular & metabolic diseases in Greater China

US-based Arrowhead Pharmaceuticals, Inc. has formed a joint venture, Visirna Therapeutics, with Vivo Capital t...

April 29, 2022 | Friday | News
Hong Kong holds first clinical trial of novel oral treatment for COVID-19

The Chinese University of Hong Kong (CUHK)’s Clinical Trial Centre has announced its collaboration with CUHK Medic...

April 28, 2022 | Thursday | News
Vietnam's POC Pharma raises $10.3 M in Series A funding

Vietnam and Hong Kong-based startup POC Pharma, a B2B service SaaS, has raised a $10.3-million Series A funding round le...

April 27, 2022 | Wednesday | News
RVAC Medicines, a CBC-Incubated mRNA platform company, raises $140 million

RVAC Medicines Pte. Ltd., an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC Group, has ann...

April 27, 2022 | Wednesday | News
Lupin partners with Yabao Pharma for paediatric formulations in China

Indian firm Lupin has entered into a strategic partnership with Yabao Pharmaceutical Co, to meet the growing demand for ...

April 27, 2022 | Wednesday | News
Biocon Biologics' Insugen bags three-year contract from Ministry of Health, Malaysia

Indian firm Biocon Biologics' subsidiary Biocon in Malaysia has been awarded a three-year contract, valued at $90 millio...

April 26, 2022 | Tuesday | News
ATUM accelerates entry of bioengineering solutions into Chinese pharmaceutical market

US-based ATUM has announced a distribution partnership with Trio Biotech to market and promote ATUM’s unique Leap-...

April 21, 2022 | Thursday | News
Korea's LG Chem pushes targeting of global atopic dermatitis market worth KRW 29 trillion

South Korea's LG Chem has announced that its Chinese counterpart TransThera Sciences received the IND clearance fro...

April 21, 2022 | Thursday | News
How far does cloud technology ensure drug safety and operational efficiencies at pharmacovigilance?

Dr. Anju Agarwal, Director, Global Patient Safety at Advanz Pharma From popular over-the-counter medications like parac...

April 12, 2022 | Tuesday | Opinion
ReiThera, Exothera to develop low cost per dose manufacturing process for delivering vaccines to LMICs

ReiThera Srl, an Italian biotech company dedicated to the technology development, GMP manufacturing and clinical transla...

April 13, 2022 | Wednesday | News
Ardelyx and Kyowa Kirin amend license agreement for Tenapanor

US' Ardelyx, has reached an agreement with its Japanese collaboration partner, Kyowa Kirin Co. Ltd., to amend the licens...

April 12, 2022 | Tuesday | News
PENTAX Medical appoints Dr Klaus Mergener as Chief Medical Officer

Japan's PENTAX Medical, a division of HOYA Group, has announced the appointment of Dr Klaus Mergener to the po...

April 11, 2022 | Monday | News
Australia-based Telix Pharmaceuticals inks oncology deal with Eli Lilly

Australia's Telix Pharmaceuticals has entered into a licence agreement with Eli Lilly and Company under which Telix is g...

April 11, 2022 | Monday | News
AGC to expand synthetic pharmaceutical production base in Spain

AGC Inc., a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand ...

April 8, 2022 | Friday | News
Orient EuroPharma gains rights to Contrave for Taiwan

Orient EuroPharma has signed a deal with the US branded and generic drugmaker Currax Pharmaceuticals to bring the weight...

April 6, 2022 | Wednesday | News
Japan's Shionogi accelerates R&D for data-driven innovation in pharmaceuticals

Japanese pharmaceutical company Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics ca...

April 7, 2022 | Thursday | News
Singlera Genomics announces research collaboration with Astellas Pharma

Singlera Genomics has announced a research collaboration with Astellas Pharma Inc. to develop methylation-based tools to...

April 6, 2022 | Wednesday | News
India's Intas Pharma signs supply agreement for Ranibizumab biosimilar in Middle East

India-based Intas Pharmaceuticals has signed an exclusive license and supply agreement with Axantia Holding, a leading p...

April 5, 2022 | Tuesday | News
Iktos, Teijin Pharma to co-develop new technology for small molecule drug discovery

French firm Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Japan's Teij...

April 6, 2022 | Wednesday | News
Ascletis seeks authorization for Ritonavir in Hong Kong

Ascletis Pharma has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the H...

April 4, 2022 | Monday | News
Chugai, Halozyme Therapeutics partner for ENHANZE Technology

US' Halozyme Therapeutics has announced a global collaboration and license agreement with Japan's Chugai Pharmaceutical ...

April 4, 2022 | Monday | News
Singapore maps future of biomanufacturing industry & catalyses recovery

The 9th Annual Biologics Manufacturing Asia 2022 & the 6th Annual BioLogistics World Asia 2022 conferences concluded...

April 4, 2022 | Monday | News
How personalised 3D-printed drugs can cut costs & eliminate fakes?

As the pharmaceutical industry moves away from mass production towards a more personalised model, 3D printing of drugs h...

April 2, 2022 | Saturday | Analysis